Attached files
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
For the
quarterly period ended September 27, 2009
or
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
For
the transition period from
|
to
|
Commission
File Number 0-14864
LINEAR
TECHNOLOGY CORPORATION
(Exact
name of registrant as specified in its charter)
DELAWARE
|
94-2778785
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer Identification No.)
|
|
incorporation
or organization)
|
||
1630 McCarthy Boulevard, Milpitas,
California
|
95035
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(408)
432-1900
(Registrant’s
telephone number, including area code)
N/A
(Former
name, former address and former fiscal year, if changed since last
report)
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.
Yes
x
|
No
o
|
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes
o
|
No
o
|
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer or a small reporting
company. See the definition of “large accelerated filing,”
“accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange
Act.
Large
accelerated filer x
|
Accelerated
filer o
|
|
Non-accelerated
filer o ( Do not check if a
smaller reporting company)
|
Smaller
reporting company o
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
Yes
o
|
No
x
|
Shares
outstanding of the Registrant’s common stock:
Class
|
Outstanding
at October 23, 2009
|
|
Common
Stock, $0.001 par value per share
|
223,115,077 shares
|
1
LINEAR
TECHNOLOGY CORPORATION
FORM
10-Q
THREE
MONTHS ENDED SEPTEMBER 27, 2009
INDEX
Page
|
|||
Part
I:
|
Financial
Information
|
||
Item
1.
|
Financial
Statements
|
||
Consolidated
Statements of Income for the three months
|
|||
ended September 27, 2009
(unaudited) and September 28, 2008 (unaudited)
|
3
|
||
Consolidated
Balance Sheets at September 27, 2009 (unaudited) and
|
|||
June
28, 2009
|
4
|
||
Consolidated
Statements of Cash Flows for the three months ended
|
|||
September 27, 2009 (unaudited)
and September 28, 2008 (unaudited)
|
5
|
||
Notes
to Consolidated Financial Statements (unaudited)
|
6-15
|
||
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and
|
||
Results of
Operations
|
16-19
|
||
Item
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
19
|
|
Item
4.
|
Controls
and Procedures
|
19-20
|
|
Part
II:
|
Other
Information
|
||
Item
1.
|
Legal
Proceedings
|
20-21
|
|
Item
1A.
|
Risk
Factors
|
21-26
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
27
|
|
Item
6.
|
Exhibits
|
28
|
|
Signatures:
|
29
|
||
2
Item
1. Financial
Statements
LINEAR
TECHNOLOGY CORPORATION
CONSOLIDATED
STATEMENTS OF INCOME
(In
thousands, except per share amounts)
(unaudited)
Three
Months Ended
|
|||||
September
27,
|
September
28,
|
||||
2009
|
2008*
|
||||
Revenues
|
$ 236,135
|
$ 310,351
|
|||
Cost
of sales (1)
|
59,583
|
71,472
|
|||
Gross
profit
|
176,552
|
238,879
|
|||
Expenses:
|
|||||
Research
and development (1)
|
45,340
|
50,860
|
|||
Selling,
general and administrative (1)
|
31,659
|
37,107
|
|||
76,999
|
87,967
|
||||
Operating
income
|
99,553
|
150,912
|
|||
Interest
expense(2)
|
(19,121)
|
(22,712)
|
|||
Interest
income
|
3,856
|
6,974
|
|||
Income
before income taxes
|
84,288
|
135,174
|
|||
Provision
for income taxes
|
23,601
|
32,867
|
|||
Net
income
|
$ 60,687
|
$ 102,307
|
|||
Basic
earnings per share
|
$ 0.27
|
$ 0.45
|
|||
Shares
used in the calculation of basic
|
|||||
earnings
per share
|
226,909
|
225,705
|
|||
Diluted
earnings per share
|
$ 0.27
|
$ 0.45
|
|||
Shares
used in the calculation of diluted
|
|||||
earnings
per share
|
227,852
|
227,700
|
|||
Cash
dividends per share
|
$ 0.22
|
$ 0.21
|
|||
Includes
the following non-cash charges:
|
|||||
(1)Stock-based
compensation
|
|||||
Cost
of sales
|
$ 2,295
|
$ 1,886
|
|||
Research
and development
|
9,719
|
7,986
|
|||
Selling,
general and administrative
|
5,475
|
4,502
|
|||
(2)Non-cash
interest expense
|
$ 7,229
|
$ 8,305
|
|||
* As
adjusted for the adoption of FSP APB14-1, now codified in ASC 470-20-10 to 35
(see Note 1)
and EITF
03-6-1, now codified in ASC 260-10-45 to 65 (see Note 1).
See
accompanying notes
3
LINEAR
TECHNOLOGY CORPORATION
CONSOLIDATED
BALANCE SHEETS
(In
thousands, except par value)
September
27,
|
June
28,
|
|||||||
2009
|
2009*
|
|||||||
(unaudited)
|
||||||||
Assets
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 247,349 | $ | 217,018 | ||||
Marketable
securities
|
662,124 | 651,693 | ||||||
Accounts
receivable, net of allowance for
|
||||||||
doubtful
accounts of $1,773 ($1,790 at June 28, 2009)
|
113,239 | 95,434 | ||||||
Inventories:
|
||||||||
Raw
materials
|
3,528 | 3,343 | ||||||
Work-in-process
|
36,336 | 38,612 | ||||||
Finished
goods
|
9,475 | 10,576 | ||||||
Total
inventories
|
49,339 | 52,531 | ||||||
Deferred
tax assets
|
36,475 | 37,628 | ||||||
Prepaid
expenses and other current assets
|
33,961 | 34,947 | ||||||
Total
current assets
|
1,142,487 | 1,089,251 | ||||||
Property,
plant and equipment, at cost:
|
||||||||
Land,
buildings and improvements
|
218,331 | 216,561 | ||||||
Manufacturing
and test equipment
|
508,402 | 506,824 | ||||||
Office
furniture and equipment
|
3,792 | 3,792 | ||||||
730,525 | 727,177 | |||||||
Accumulated
depreciation and amortization
|
(478,903 | ) | (468,752 | ) | ||||
Property,
plant and equipment, net
|
251,622 | 258,425 | ||||||
Other
non current assets
|
72,293 | 73,853 | ||||||
Total
assets
|
$ | 1,466,402 | $ | 1,421,529 | ||||
Liabilities
and stockholders’ deficit
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ | 9,220 | $ | 10,531 | ||||
Accrued
payroll and related benefits
|
40,555 | 44,250 | ||||||
Deferred
income on shipments to distributors
|
27,298 | 28,497 | ||||||
Income
taxes payable
|
27,658 | 9,718 | ||||||
Other
accrued liabilities
|
44,366 | 32,345 | ||||||
Total
current liabilities
|
149,097 | 125,341 | ||||||
Deferred
tax liabilities
|
109,187 | 107,514 | ||||||
Convertible
senior notes
|
1,278,278 | 1,280,617 | ||||||
Other
long-term liabilities
|
93,618 | 94,394 | ||||||
Total
liabilities
|
1,630,180 | 1,607,866 | ||||||
Commitments
and contingencies
|
||||||||
Stockholders’
deficit:
|
||||||||
Preferred
stock, $0.001 par value, 2,000 shares authorized;
|
||||||||
none
issued or outstanding
|
- | - | ||||||
Common
stock, $0.001 par value, 2,000,000 shares authorized;
|
||||||||
222,643
shares issued and outstanding at September 27, 2009
|
||||||||
(222,276
shares at June 28, 2009)
|
223 | 222 | ||||||
Additional
paid-in capital
|
1,262,628 | 1,246,870 | ||||||
Accumulated
other comprehensive income, net of tax
|
4,590 | 5,095 | ||||||
Accumulated
deficit
|
(1,431,219 | ) | (1,438,524 | ) | ||||
Total
stockholders’ deficit
|
(163,778 | ) | (186,337 | ) | ||||
Total
liabilities and stockholders’ deficit
|
$ | 1,466,402 | $ | 1,421,529 |
* Derived
from audited financial statements at June 28, 2009 as adjusted for the adoption
of
FSP
APB14-1, now codified in ASC
470-20-10 to 35 (see Note 1).
See
accompanying notes
4
LINEAR
TECHNOLOGY CORPORATION
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(In
thousands)
(unaudited)
Three
Months Ended
|
||||||||
September
27,
|
September
28,
|
|||||||
2009
|
2008
|
|||||||
Cash
flow from operating activities:
|
||||||||
Net
income
|
$ | 60,687 | $ | 102,307 | ||||
Adjustments
to reconcile net income to
|
||||||||
net
cash provided by operating activities:
|
||||||||
Depreciation
and amortization
|
11,677 | 11,893 | ||||||
Tax
(deficit) benefit received on the exercise of
|
||||||||
stock-based
awards
|
(1,644 | ) | 37 | |||||
Stock-based
compensation
|
17,489 | 14,374 | ||||||
Amortization
of convertible senior notes discount
|
7,229 | 8,305 | ||||||
Change
in operating assets and liabilities:
|
||||||||
Increase
in accounts receivable
|
(17,805 | ) | (1,787 | ) | ||||
Decrease
in inventories
|
3,192 | 551 | ||||||
Decrease
in prepaid expenses, other
|
||||||||
current
assets and deferred tax assets
|
2,162 | 2,398 | ||||||
Decrease
in long-term assets
|
111 | 1,201 | ||||||
Increase
(decrease) in accounts payable,
|
||||||||
accrued
payroll and other accrued liabilities
|
5,223 | (4,668 | ) | |||||
Decrease
in deferred income on
|
||||||||
shipments
to distributors
|
(1,199 | ) | (1,787 | ) | ||||
Increase
in income taxes payable
|
19,921 | 11,732 | ||||||
Increase
in long-term liabilities
|
1,016 | 25 | ||||||
Cash
provided by operating activities
|
108,059 | 144,581 | ||||||
Cash
flow from investing activities:
|
||||||||
Purchases
of marketable securities
|
(94,165 | ) | (172,418 | ) | ||||
Proceeds
from sales and maturities of
|
||||||||
available-for-sale
securities
|
82,898 | 162,320 | ||||||
Purchases
of property, plant and equipment
|
(3,359 | ) | (23,064 | ) | ||||
Cash
used in investing activities
|
(14,626 | ) | (33,162 | ) | ||||
Cash
flow from financing activities:
|
||||||||
Retirement
of convertible senior notes
|
(9,815 | ) | - | |||||
Excess
tax benefit received on exercise of
|
||||||||
stock-based
awards
|
- | 70 | ||||||
Issuance
of common stock under employee
|
||||||||
stock
plans
|
893 | 5,104 | ||||||
Purchases
of common stock
|
(4,243 | ) | (23,105 | ) | ||||
Payments
of cash dividends
|
(49,937 | ) | (47,365 | ) | ||||
Cash
used in financing activities
|
(63,102 | ) | (65,296 | ) | ||||
Increase
in cash and cash equivalents
|
30,331 | 46,123 | ||||||
Cash
and cash equivalents, beginning of period
|
217,018 | 149,221 | ||||||
Cash
and cash equivalents, end of period
|
$ | 247,349 | $ | 195,344 |
See
accompanying notes
5
LINEAR
TECHNOLOGY CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1.
|
Basis
of Presentation
|
|
Interim
financial statements and information are unaudited; however, in the
opinion of management, all adjustments necessary for a fair and accurate
presentation of the interim results have been made. All such
adjustments were of a normal recurring nature. The results for
the three month period ended September 27, 2009 are not necessarily an
indication of results to be expected for the entire fiscal
year. All information reported in this Form 10-Q should be read
in conjunction with the Company’s annual consolidated financial statements
for the fiscal year ended June 28, 2009 included in the Company’s Annual
Report on Form 10-K. The accompanying balance sheet at June 28,
2009 has been derived from audited financial statements as of that date as
adjusted for the adoption of FSP APB 14-1, now codified in ASC 470-20-10
to 35 and EITF 03-6-1, now codified in ASC 260-10-45 to 65, each discussed
below. Because the Company is viewed as a single operating
segment for management purposes, no segment information has been
disclosed.
|
Recently
Adopted Accounting Standards
Accounting
Standards Codification
In June
2009, the Financial Accounting Standards Board (“FASB”) issued FASB Statement
No. 168, The FASB
Accounting Standards Codification™ and the Hierarchy of Generally Accepted
Accounting Principles (“SFAS 168”). SFAS 168 establishes the FASB
Accounting Standards Codification (“ASC”) as the single source of authoritative
U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to
be applied by non-governmental entities. Rules and interpretive releases of the
Securities and Exchange Commission (“SEC”) under authority of federal securities
laws are also sources of authoritative GAAP for SEC registrants. The ASC
supersedes all existing non-SEC accounting and reporting standards. All other
non-grandfathered, non-SEC accounting literature not included in the ASC will
become non-authoritative.
Following
the ASC, the FASB will not issue new standards in the form of Statements, FASB
Staff Positions or Emerging Issues Task Force Abstracts. Instead, it
will issue Accounting Standards Updates, which will serve to update the ASC,
provide background information about the guidance and provide the basis for
conclusions on the changes to the ASC.
GAAP is
not intended to be changed as a result of the ASC project, but it will change
the way the guidance is organized and presented. As a result, these changes will
have a significant impact on how companies reference GAAP in their financial
statements and in their accounting policies for financial statements issued for
interim and annual periods ending after September 15, 2009. The Company has
adopted this guidance in this quarterly report by providing references to the
ASC topics alongside references to the previous standards.
Standard
for Convertible Senior Notes
The
provisions of FASB Staff Position (FSP) No. APB 14-1, Accounting for Convertible Debt
Instruments That May Be Settled in Cash upon Conversion (including Partial Cash
Settlement) (“FSP APB14-1”), now codified in ASC Topic 470-20-10 to 35,
Debt (ASC 470-20-10 to
35) were applicable to the Company in the first quarter of fiscal year 2010. The
Company was required to retrospectively adopt the provisions of ASC 470-20-10 to
35. The adoption of ASC 470-20-10 to 35 affected the
accounting treatment of the Company’s 3.00% Convertible Senior Notes due May 1,
2027 (the “2027A notes”) and its 3.125% Convertible Senior Notes due May 1, 2027
(the “2027B notes” and, together with the 2027A notes, the
“Notes”). ASC 470-20-10 to 35 specifies that issuers of convertible
debt instruments such as the Notes, should separately account for the liability
(debt) and equity (conversion option) components of such instruments in a manner
that reflects the borrowing rate for a similar non-convertible debt
instrument. The liability component is recognized as the fair value
of a similar instrument that does not have a conversion feature at the time of
issuance. The equity component is based on the excess of the
principal amount of the Notes over the fair value of the liability component,
after adjusting for the deferred tax impact. Such excess represents
the estimated fair value of the conversion feature and is recorded as additional
paid-in capital. The Company’s 2027A notes and 2027B notes were issued at coupon
rates of 3.00% and 3.125%, respectively, which were below that of similar
instruments that do not have conversion features (5.69% and 5.35%,
respectively.) Therefore, the valuation of the debt component
resulted in a discounted carrying value of the Notes compared to the principal
amounts. This debt discount is amortized as additional non-cash
interest expense over the expected life of the debt, which is 7 years for the
2027A notes and 3.5 years for the 2027B notes. The consolidated
balance sheet at June 28, 2009 and the consolidated statements of income and
cashflows for the three months ended September 27, 2009 have been
retrospectively adjusted for all periods presented in accordance with ASC
470-20-10 to 35. See “Note 8. Convertible Senior Notes” for further
information relating to the adoption of ASC 470-20-10 to 35.
6
The
effect of the retrospective adoption of ASC 470-20-10 to 35 on individual line
items on the Company’s consolidated balance sheet at June 28, 2009 was as
follows:
In
thousands
|
June
28, 2009
|
|||||||||||
As
Previously Reported
|
Adjustments
|
As
Adjusted
|
||||||||||
Deferred
tax liabilities
|
$ | 62,752 | $ | 44,762 | $ | 107,514 | ||||||
Convertible
Senior Notes
|
1,405,644 | (125,027 | ) | 1,280,617 | ||||||||
Additional
paid-in capital
|
1,119,147 | 127,723 | 1,246,870 | |||||||||
Accumulated
deficit
|
(1,391,066 | ) | (47,458 | ) | (1,438,524 | ) | ||||||
The
effect of the retrospective adoption of ASC 470-20-10 to 35 on individual line
items on the Company’s consolidated statement of income for the first quarter of
fiscal year 2009 was as follows:
In
thousands, excepts per share amounts
|
Three
months ended September 28, 2008
|
|||||||||||
As
Previously Reported
|
Adjustments
|
As
Adjusted
|
||||||||||
Interest
expense
|
$ | 14,407 | $ | 8,305 | $ | 22,712 | ||||||
Provision
for income taxes
|
35,870 | (3,003 | ) | 32,867 | ||||||||
Net
income
|
107,609 | (5,302 | ) | 102,307 | ||||||||
Basic
earnings per share
|
0.49 | (0.04 | ) | 0.45 | ||||||||
Diluted
earnings per share
|
0.48 | (0.03 | ) * | 0.45 |
|
*As
adjusted for the adoption of EITF 03-6-1, now codified in ASC 260-10-45 to
65.
|
Standard
for Earnings per Share (“EPS”) Calculation
The provisions of FSP No. EITF 03-6-1, Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities (“EITF 03-6-1”), now codified in ASC Topic 260-10-45 to 65, Earnings Per Share (ASC 260-10-45 to 65) were applicable to the Company in the first quarter of fiscal year 2010. Under ASC 260-10-45 to 65, unvested share-based payment awards that contain non-forfeitable rights to dividends, such as the Company’s restricted stock awards, are considered to be a separate class of common stock and should be included in the EPS calculation using the “two-class method.” In accordance with the ASC 260-10-45 to 65, restricted awards are now included in the basic and diluted EPS calculations.
The
effect of the retrospective adoption of ASC 260-10-45 to 65 on individual line
items on the Company’s consolidated statement of income for the first quarter of
fiscal year 2009 was as follows:
In
thousands
|
Three
months ended September 28, 2008
|
|||||||||||
As
Previously Reported
|
Adjustments
|
As
Adjusted
|
||||||||||
Shares
used in the calculation
of basic earnings
per share
|
221,433 | 4,272 | 225,705 | |||||||||
Shares
used in the calculation
of diluted earnings
per share
|
224,091 | 3,609 | 227,700 |
Fair
Value of Financial Instruments.
In April
2009, the FASB issued FSP No. FAS 107-1 and APB 28-1, Interim Disclosures about Fair Value
of Financial Instruments (“FSP FAS 107-1 and APB 28-1”), now codified in
ASC Topic 825, Financial
Instruments (ASC 825), which requires disclosure in the body or in the
accompanying notes of the Company’s summarized financial information for interim
reporting periods and in its financial statements for annual reporting periods,
of the fair value of all financial instruments for which it is practicable to
estimate that value, whether recognized or not in the statement of financial
position. The Company adopted this guidance in the first quarter of fiscal year
2010. The adoption had no financial impact on the Company’s consolidated
statement of income or financial condition. (See Note 5, “Marketable
Securities”).
7
Revenue
Recognition
The
Company recognizes revenues when the earnings process is complete, when
persuasive evidence of an arrangement exists, the product has been delivered,
the price is fixed and determinable and collection is reasonably
assured. During the first quarter of fiscal year 2010, the Company
recognized approximately 15% of net revenues from domestic distributors that are
recognized under agreements which provide for certain sales price rebates and
limited product return privileges. Given the uncertainties associated
with the levels of pricing rebates, the ultimate sales price on domestic
distributor sales transactions is not fixed or determinable until domestic
distributors sell the merchandise to the end-user. At the time of
shipment to domestic distributors, the Company records a trade receivable and
deferred revenue at the distributor purchasing price since there is a legally
enforceable obligation from the distributor to pay for the products
delivered. The Company relieves inventory as title has passed to the
distributor and recognizes deferred cost of sales in the same amount. “Deferred
income on shipments to distributors” represents the difference between deferred
revenue and deferred cost of sales and is recognized as a current liability
until such time as the distributor confirms a final sale to its end customer.
At September 27, 2009, the Company had approximately $33.2 million of
deferred revenue and $5.9 million of deferred cost of sales recognized as $27.3
million of “Deferred income on shipments to distributors.” The
Company believes that its deferred costs of revenues have limited risk of
material impairment as the Company offers stock rotation privileges to
distributors (up to 3% to 5% of quarterly purchases) which enable distributors
to rotate slow moving inventory. In addition, stock rotated inventory that is
returned to the Company is generally resalable. The Company reviews
distributor ending on-hand inventory balances, as well as orders placed on the
Company to ensure that distributors are not overstocking parts and are ordering
to forecasted demand. To the extent the Company had a significant reduction in
distributor price or grants significant price rebates, there could be a material
impact on the ultimate revenue and gross profit recognized. The price rebates
that have been remitted back to distributors have generally ranged from $1.5
million to $3.1 million per quarter.
The
Company’s sales to international distributors are made under agreements which
permit limited stock return privileges but not sales price
rebates. Revenue on these sales is recognized upon shipment at which
time title passes. The Company has reserves to cover expected product
returns. If product returns for a particular fiscal period exceed or
are below expectations, the Company may determine that additional or less sales
return allowances are required to properly reflect its estimated exposure for
product returns. Generally, changes to sales return allowances have
not had a significant impact on operating margin.
Subsequent
Events
The Company has evaluated subsequent
events through November 5, 2009, the date of issuance of consolidated financial
statements. During the period from September 27, 2009 to November 5, 2009, the
Company did not have any material recognizable subsequent events.
2.
|
Fiscal
Period
|
The
Company operates on a 52/53-week fiscal year ending on the Sunday nearest June
30. Fiscal years 2010 and 2009 are 52-week years.
8
3.
|
Earning
Per Share
|
|
Basic
earnings per share is calculated using the weighted average shares of
common stock outstanding during the period. Diluted earnings
per share is calculated using the weighted average shares of common stock
outstanding, plus the dilutive effect of stock options and restricted
stock calculated using the treasury stock method. The following
table sets forth the reconciliation of weighted average common shares
outstanding used in the computation of basic and diluted earnings per
share:
|
Three
Months Ended
|
||||||||
In
thousands, except per share
|
September
27,
|
September
28,
|
||||||
amounts
|
2009
|
2008*
|
||||||
Numerator
- net income
|
$ | 60,687 | $ | 102,307 | ||||
Denominator
for basic earnings
|
||||||||
per
share- weighted
|
||||||||
average
shares
|
226,909 | 225,705 | ||||||
Effect
of dilutive securities –
|
||||||||
employee
stock options
|
943 | 1,995 | ||||||
Denominator
for diluted earnings
|
||||||||
per
share
|
227,852 | 227,700 | ||||||
Basic
earnings per share
|
$ | 0.27 | $ | 0.45 | ||||
Diluted
earnings per share
|
$ | 0.27 | $ | 0.45 |
* As
adjusted for the adoption of ASC 470-20-10 to 35 (see Note 1) and ASC 260-10-45
to 65 (see Note 1).
4.
|
Fair
Value
|
The
Company reviewed all assets and liabilities recorded on its balance sheet as of
September 27, 2009. Based on the results of its review, the Company determined
that the only assets and liabilities in the Company’s financial statements that
are required to be measured at fair value on a recurring basis are the Company’s
investment portfolio assets. GAAP establishes a fair value hierarchy
that prioritizes the inputs to valuation techniques used to measure fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active
markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). Fair
value is the price that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants on the
measurement date. A fair value measurement assumes that the transaction to sell
the asset or transfer the liability occurs in the principal market for the asset
or liability. The three levels of the fair value hierarchy are described
below:
Level
1. Valuations based on
quoted prices in active markets for identical assets or liabilities that an
entity has the ability to access.
The
Company’s Level 1 assets consist of investments in money-market funds and United
States Treasury securities that are actively traded.
Level
2. Valuations based on
quoted prices for similar assets or liabilities, quoted prices for identical
assets or liabilities in markets that are not active, or other inputs that are
observable or can be corroborated by observable data for substantially the full
term of the assets or liabilities.
The
Company’s Level 2 assets consist of municipal bonds, obligations of U.S.
government-sponsored enterprises, corporate debt and commercial paper that are
less actively traded in the market, but where quoted market prices exist for
similar instruments that are actively traded. The Company determines the fair
value of its Level 2 assets by obtaining non-binding market prices from its
third-party portfolio managers on the last day of the quarter.
Level 3.
Valuations based on inputs that are supported by little or no market
activity and that are significant to the fair value of the assets or
liabilities.
The
Company has no Level 3 assets.
9
The
following table presents the Company’s fair value hierarchy for its financial
assets (cash equivalents and marketable securities) measured at fair value on a
recurring basis as of September 27, 2009:
In
thousands
|
Quoted
Prices in
|
|||||||||||
Active
Markets
|
Significant
Other
|
|||||||||||
for
Identical
|
Observable
Inputs
|
|||||||||||
Description
|
Instruments
(Level 1)
|
(Level
2)
|
Total
|
|||||||||
Assets
|
||||||||||||
Investments
in U.S. Treasury
securities
and money-market funds
|
$ | 166,604 | $ | - | $ | 166,604 | ||||||
Investments
in municipal bonds,
obligations
of U.S. government-
sponsored
enterprises, corporate debt
and
commercial paper
|
- | 640,450 | 640,450 | |||||||||
Total
assets measured at fair value
|
$ | 166,604 | $ | 640,450 | $ | 807,054 |
|
During
the fourth quarter of fiscal year 2007, the Company issued $1.0 billion
aggregate principal amount of its 3.00% Convertible Senior Notes due May
1, 2027 (the “2027A notes”) and $700 million aggregate principal amount of
its 3.125% Convertible Senior Notes due May 1, 2027 (the “2027B notes”
and, together with the 2027A notes, the “Notes”) to an initial purchaser
in a private offering. Through the first quarter of fiscal year
2010, the Company has repurchased $304.2 million in principal amount of
its 2027B Notes. As a result of the
repurchases in fiscal year 2009 and the first quarter of fiscal year 2010,
the remaining principal amount of the Notes as of September 27, 2009 was
$1,396 million. The fair value of the Notes as of September 27, 2009 was
approximately $1,348 million, based on the last trading prices of the
Notes which was September 25,
2009.
|
5. Marketable
Securities
The
following is a summary of cash equivalents and marketable securities at
September 27, 2009 and June 28, 2009:
September
27, 2009
|
||||||||||||||||
In
thousands
|
Amortized
|
Unrealized
|
Unrealized
|
Fair
|
||||||||||||
Cost
|
Gain
|
(Loss)
(1)
|
Value
|
|||||||||||||
U.S.
Treasury securities
|
$ | 80,027 | $ | 473 | $ | - | $ | 80,500 | ||||||||
Obligations
of U.S. government-sponsored enterprises
|
99,168 | 890 | (12 | ) | 100,046 | |||||||||||
Municipal
bonds
|
462,564 | 5,844 | (9 | ) | 468,399 | |||||||||||
Corporate
debt securities and other
|
71,878 | 130 | (3 | ) | 72,005 | |||||||||||
Money
market funds
|
86,104 | - | - | 86,104 | ||||||||||||
Total
|
$ | 799,741 | $ | 7,337 | $ | (24 | ) | $ | 807,054 | |||||||
Amounts
included in:
|
||||||||||||||||
Cash
equivalents
|
$ | 144,930 | $ | - | $ | - | $ | 144,930 | ||||||||
Marketable
Securities
|
654,811 | 7,337 | (24 | ) | 662,124 | |||||||||||
Total
|
$ | 799,741 | $ | 7,337 | $ | (24 | ) | $ | 807,054 |
June
28, 2009
|
||||||||||||||||
In
thousands
|
Amortized
|
Unrealized
|
Unrealized
|
Fair
|
||||||||||||
Cost
|
Gain
|
(Loss)
(1)
|
Value
|
|||||||||||||
U.S.
Treasury securities
|
$ | 65,297 | $ | 696 | $ | - | $ | 65,993 | ||||||||
Obligations
of U.S. government-sponsored enterprises
|
96,153 | 1,075 | (2 | ) | 97,226 | |||||||||||
Municipal
bonds
|
459,006 | 6,208 | (15 | ) | 465,199 | |||||||||||
Corporate
debt securities and other
|
26,283 | 187 | - | 26,470 | ||||||||||||
Money
market funds
|
139,843 | - | - | 139,843 | ||||||||||||
Total
|
$ | 786,582 | $ | 8,166 | $ | (17 | ) | $ | 794,731 | |||||||
Amounts
included in:
|
||||||||||||||||
Cash
equivalents
|
$ | 143,038 | $ | - | $ | - | $ | 143,038 | ||||||||
Marketable
Securities
|
643,544 | 8,166 | (17 | ) | 651,693 | |||||||||||
Total
|
$ | 786,582 | $ | 8,166 | $ | (17 | ) | $ | 794,731 |
10
(1) The
Company evaluated the nature of the investments with a loss position at
September 27, 2009 and June 28, 2009, which are primarily obligations of the
U.S. government and its sponsored enterprises, municipal bonds and U.S.
corporate notes. In evaluating the investments, the Company
considered the duration of the impairments, and the amount of the impairments
relative to the underlying portfolio and concluded that such amounts were not
other-than-temporary. The Company principally holds securities until maturity,
however, they may be sold under certain circumstances. Unrealized
losses on the investments greater than twelve months old were not significant as
of September 27, 2009 and June 28, 2009.
The
estimated fair value of investments in debt securities by effective maturity
date, is as follows:
In
thousands
|
September
27,
|
June
28,
|
||||||
2009
|
2009
|
|||||||
Due
in one year or less
|
$ | 308,367 | $ | 268,139 | ||||
Due
after one year through three years
|
353,757 | 383,554 | ||||||
Total
|
$ | 662,124 | $ | 651,693 |
6.
|
Stock-Based
Compensation
|
Equity Incentive Plans
The
Company has two equity incentive plans under which the Company may grant
incentive stock options, nonstatutory stock options, stock appreciation rights,
restricted stock, restricted stock units, performances shares and performance
units. Under the plans (the 2005 Equity Incentive Plan and the 2001
Nonstatutory Stock Option Plan), the Company may grant awards to employees,
executive officers, directors and consultants who provide services to the
Company. To date, the Company has only granted nonstatutory stock
options, restricted stock and restricted stock units from these
plans. At September 27, 2009, 8.1 million shares were available for
grant under the plans. The Employee Stock Purchase Plan (“ESPP”)
permits eligible employees to purchase common stock through payroll deductions
at 85% of the fair market value of the common stock at the end of each offering
period. The offering periods generally commence on approximately May
1 and November 1 of each year, although the current offering period is scheduled
to end on November 6, 2009, and the next period will begin on November 9,
2009. At September 27, 2009, 0.1 million shares were available
for issuance under the ESPP. The Company’s stockholders approved
a 2.0 million share increase to the ESPP at the 2009 Annual Meeting of
Stockholders on November 4, 2009.
Accounting for Stock-Based
Compensation
Compensation
cost for restricted stock awards is based on the fair market value of the
Company’s stock on the date of grant. Compensation cost for stock
options is calculated on the date of grant using the fair value of stock options
as determined using the Black-Scholes valuation model. The Company
amortizes the compensation cost straight-line over the vesting period, which is
generally five years. The Black-Scholes valuation model requires the
Company to estimate key assumptions such as expected option term, stock price
volatility and forfeiture rates to determine the fair value of a stock option.
The estimate of these key assumptions is based on historical information and
judgment regarding market factors and trends.
As of
September 27, 2009, there was approximately $165.6 million of total unrecognized
stock-based compensation cost related to share-based payments granted under the
Company’s stock-based compensation plans that will be recognized over a period
of approximately five years. Future grants will add to this total,
whereas quarterly amortization and the vesting of the existing grants will
reduce this total. The Company issues new shares of common stock upon
exercise of stock options. For the three months ended September 27, 2009,
options for approximately 38,000 shares were exercised for a gain (aggregate
intrinsic value) of $0.1 million determined as of the date of option
exercise.
11
Stock
Options
The
following table summarizes stock option activity and related information under
all stock option plans during the period indicated:
|
Weighted-
|
|||||||
Stock
|
Average
|
|||||||
Options
|
Exercise
|
|||||||
Outstanding
|
Price
|
|||||||
Outstanding
options, June 28, 2009
|
28,945,556 | $ | 34.15 | |||||
Granted
|
- | - | ||||||
Forfeited
and expired
|
(1,372,186 | ) | 33.87 | |||||
Exercised
|
(38,312 | ) | 23.32 | |||||
Outstanding
options, September 27, 2009
|
27,535,058 | $ | 34.18 | |||||
Options
vested and exercisable at:
|
||||||||
September
27, 2009
|
21,656,163 | $ | 37.24 |
Restricted
Stock
The
following table summarizes the Company’s restricted stock and restricted stock
unit activity under all equity award plans during the period
indicated:
Restricted
Awards Outstanding
|
Weighted-Average
Grant-Date Fair Value
|
|||||||
Nonvested
at June 28, 2009
|
5,296,490 | $ | 30.72 | |||||
Granted
|
272,115 | 27.21 | ||||||
Vested
|
(487,452 | ) | 32.86 | |||||
Forfeited
|
(42,932 | ) | 28.95 | |||||
Nonvested
at September 27, 2009
|
5,038,221 | $ | 30.33 |
7. Comprehensive
Income
Accumulated
other comprehensive income consists of unrealized gains or losses on
available-for-sale securities. The components of comprehensive income
were as follows:
Three
Months Ended
|
||||||||
In
thousands
|
September
27,
|
September
28,
|
||||||
2009
|
2008*
|
|||||||
Net
income
|
$ | 60,687 |
$
102,307
|
|||||
Changes
in unrealized gains on
|
||||||||
available-for-sale
securities
|
(505 | ) | (742 | ) | ||||
Total
comprehensive income
|
$ | 60,182 | $ | 101,565 |
* As
adjusted for the adoption of ASC 470-20-10 to 35 (see Note 1).
12
8. Convertible
Senior Notes
During the fourth quarter of fiscal
year 2007, the Company issued $1.0 billion aggregate principal amount of its
3.00% Convertible Senior Notes due May 1, 2027 (the “2027A notes”) and $700
million aggregate principal amount of its 3.125% Convertible Senior Notes due
May 1, 2027 (the “2027B notes” and, together with the 2027A notes, the “Notes”)
to an initial purchaser in a private offering. The Company received
net proceeds from the issuance of the Notes of $1,678.0 million after the
deduction of issuance costs of $22.0 million. The Company used the
entire net proceeds of the offering to fund a portion of its repurchase of $3.0
billion of its common stock pursuant to an accelerated stock repurchase
transaction it entered into with an affiliate of the initial purchaser of the
Notes simultaneously with the offering of the Notes. Through the
first quarter of fiscal year 2010 the Company has repurchased $304.2 million
(principal amount) of its 2027B notes resulting in approximately $1.4 billion
(principal amount) of debt outstanding as of September 27, 2009. Interest is
payable semiannually in arrears on May 1 and November 1, beginning on November
1, 2007.
Upon
conversion of the Notes, the Company will pay the holder cash equal to the
lesser of the aggregate principal amount or the conversion value of the Notes
being converted. If the conversion value exceeds $1,000, the Company must also
deliver cash or common stock or a combination of cash and common stock, at the
Company’s option, for the conversion value in excess of $1,000 (“conversion
spread”). The conversion value of the Notes is determined based on a daily
conversion value calculated on a proportionate basis for each trading day in a
20 trading day conversion reference period. For purposes of
calculating earnings per share, there would be no adjustment to the shares in
the earnings per share calculation for the cash settled portion of the Notes, as
that portion of the debt instrument will always be settled in cash. The
conversion spread will be included in the shares for the calculation of diluted
earnings per share to the extent the conversion price is dilutive under the
treasury stock method. At September 27, 2009, no shares related to
the Notes were included in the computation of diluted earnings per
share.
As of the
date hereof, the conversion rate of the 2027A notes is 21.3268 shares of
common stock per $1,000 principal amount of the 2027A notes, subject to
adjustment upon the occurrence of certain events as described in the Indenture
for the 2027A notes (including the payment of dividends). As of the
date hereof, the conversion rate of the 2027B notes is 21.1283 shares of common
stock per $1,000 principal amount of the 2027B notes, subject to adjustment upon
the occurrence of certain events as described in the Indenture for the 2027B
notes (including the payment of dividends). The payment of the
dividend approved by the Company’s Board of Directors in October 2009 will cause
a further minor adjustment in the conversion rate of the Notes. The Company may
redeem the 2027A notes for cash at any time on or after May 1, 2014, and holders
may require the Company to repurchase the 2027A notes for cash on specified
dates or upon a fundamental change. The Company may redeem the 2027B
notes for cash at any time on or after November 1, 2010, and holders may require
the Company to repurchase the 2027B notes for cash on specified dates or upon a
fundamental change.
In the
first quarter of fiscal year 2010, the Company retrospectively adopted the
provisions of ASC 470-20-10 to 35. ASC 470-20-10 to 35 specifies that issuers of
convertible debt instruments should separately account for the liability (debt)
and equity (conversion option) components of such instruments in a manner that
reflects the borrowing rate for a similar non-convertible debt
instrument. The 2027A and 2027B notes pay cash interest of 3.0% and 3.125%,
respectively. As a result of adopting the provisions of ASC 470-20-10 to 35
during the first quarter of fiscal year 2010 the Company recognizes an effective
interest rate of 5.69% on the carrying value of the 2027A notes and 5.35%
on the carrying value of the 2027B notes. The
effective rates are based on the interest rates of similar instruments
issued at the time of issuance of the Notes that do not have conversion features
such as the Notes. The differences between the effective interest rates of 5.69%
and 5.35% and the coupon rates of 3.0% and 3.125%, results in non-cash interest
expense that will never be paid by the Company.
See
“Standard for Convertible Debentures” included in “Note 1. Basis of
Presentation” for further information relating to the adoption of ASC 470-20-10
to 35 and adjustments made to the Company’s consolidated statement of income for
the first quarter of fiscal year 2009 and consolidated balance sheet at June 28,
2009.
The
carrying values of the liability and equity components of the Notes, after the
retrospective adoption of ASC 470-20-10 to 35 are reflected in the Company’s
condensed consolidated balance sheets as follows:
September
27,
|
June
28,
|
|||||||
In
thousands
|
2009
|
2009
|
||||||
Liability
components
|
||||||||
Principal amount of the
Note
|
$ | 1,395,829 | $ | 1,405,644 | ||||
Unamortized discount of
liability component*
|
(117,551 | ) | (125,027 | ) | ||||
Carrying value of liability
component
|
$ | 1,278,278 | $ | 1,280,617 | ||||
Equity
component-net carrying value
|
$ | 127,542 | $ | 127,723 |
13
*The
remaining unamortized debt discount will be amortized as additional non-cash
interest expense over the remaining terms of the 2027A notes and 2027B
notes, which are approximately 4.6 years and 1 year, respectively, the
dates at which the Notes become redeemable.
Interest
expense related to the Notes included in interest expense on the condensed
consolidated statements of income was recognized as follows:
September
27,
|
September
28,
|
|||||||
In
thousands
|
2009
|
2008
|
||||||
Contractual coupon
interest
|
$ | 10,644 | $ | 12,969 | ||||
Amortization of debt
discount
|
7,229 | 8,305 | ||||||
Amortization of debt issuance
costs
|
971 | 1,098 | ||||||
Total
interest expense related to the Notes
|
$ | 18,844 | $ | 22,372 | ||||
9. Product
Warranty and Indemnification
The
Company’s warranty policy provides for the replacement of defective
parts. In certain large contracts, the Company has agreed to
negotiate in good faith a product warranty in the event that an epidemic failure
of its parts were to take place. To date there have been no such
occurrences. Warranty expense historically has been
negligible.
The
Company provides a limited indemnification for certain customers against
intellectual property infringement claims related to the Company's products. In
certain cases, there are limits on and exceptions to the Company's potential
liability for indemnification relating to intellectual property infringement
claims. To date, the Company has not incurred any significant
indemnification expenses relating to intellectual property infringement
claims. The Company cannot estimate the amount of potential future
payments, if any, that the Company might be required to make as a result of
these agreements, and accordingly, the Company has not accrued any amounts for
its indemnification obligations.
10. Income
Taxes
The
Company must recognize the tax benefit from an uncertain tax position only if it
is more likely than not that the tax position will be sustained on examination
by the taxing authorities, based on the technical merits of the position. The
tax benefits recognized in the financial statements from such a position are
measured based on the largest benefit that has a greater than fifty percent
likelihood of being realized upon ultimate resolution. As of September 27, 2009,
the Company’s other long-term liabilities account includes $67.2 million of
unrecognized tax benefits which, if recognized, would favorably impact its
effective income tax rate in future periods. The Company’s policy is
to recognize interest and/or penalties related to income tax matters in income
tax expense. Included in the liability for unrecognized tax benefits was $12.4
million accrued for interest at September 27, 2009.
The
Company’s annual effective income tax rate for the first quarter of fiscal year
2010 includes the research & development tax credit (“R&D credit”) for
only half the fiscal year as the R&D credit is scheduled to expire on
December 31, 2009. If the R&D credit is reinstated, as has
occurred on several occasions in the past, effective January 1, 2010 then the
Company’s effective tax rate will receive a tax benefit in future periods
including a discrete tax benefit in the quarter of reinstatement.
During
the first quarter of fiscal year 2009, the Company and the Appeals Division of
the Internal Revenue Service (“IRS Appeals”) agreed to settle certain disputed
export tax benefits the Company claimed as its extraterritorial income (“ETI”)
exclusion under the Internal Revenue Code for fiscal years 2002 through
2006. As a result of the settlement, the Company recognized a
discrete tax benefit during the first quarter of fiscal 2009 totaling $6.7
million, primarily due to the reversal of liabilities for uncertain tax
positions pertaining to ETI. IRS Appeals continues to consider
additional claims related to these tax years which have not yet been
settled. It is expected that these claims will be resolved within the
current fiscal year, at which time the Company, if it prevails, will record
additional unrecognized tax benefits to the extent the claims are accepted by
IRS Appeals.
11. Contingencies
14
Litigation
The
Company is subject to various legal proceedings and claims that arise in the
ordinary course of business on a wide range of matters, including, among others,
patent suits and employment claims. The Company does not believe that
any such current suits will have a material impact on its business or financial
condition. However, current lawsuits and any future lawsuits will
divert resources and could result in the payment of substantial
damages.
Certain
current and former directors and officers of the Company have been named as
defendants in two shareholder derivative actions filed in the United States
District Court for the Northern District of California, which have been
consolidated under the caption In re Linear Technology Corporation
Shareholder Derivative Litigation (the “Federal Action”), in three
consolidated shareholder derivative actions filed in the Superior Court for
Santa Clara County, California, also captioned In re Linear Technology Corporation
Shareholder Derivative Litigation (the “California State Action”), and in
a shareholder derivative action filed in Delaware Chancery Court, captioned
Weiss v. Swanson (the
“Delaware Action”). The Company has been named in each of these
Actions as a nominal defendant against which no recovery is sought.
In the
Federal Action, the plaintiffs alleged that the individual defendants breached
their fiduciary duties to the Company in connection with the alleged backdating
of stock option grants during the period from 1995 through 2002, and asserted
derivative claims against the individual defendants based on alleged violations
of Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”)
and Rule 10b-5 promulgated thereunder. On December 7, 2006, the Court
granted Linear’s motion to dismiss the complaint for failure to make a pre-suit
demand or to demonstrate that such a demand would have been
futile. The plaintiffs filed an amended complaint on January 5, 2007
asserting derivative claims against the individual defendants for alleged
violations of Sections 10(b), 14(a), and 20(a) of the Exchange Act, and Rules
10b-5 and 14a-9 promulgated thereunder. Pursuant to the parties’
stipulation, on February 14, 2007, the District Court entered an order staying
the Federal Action in favor of permitting the California State Action to
proceed.
In the
California State Action, the plaintiffs initially asserted claims against the
individual defendants for breaching, and aiding and abetting breaches of,
fiduciary duty in connection with the alleged backdating of stock option grants
during the period from 1995 through 2002. The plaintiffs also alleged
that certain defendants were unjustly enriched, that defendants wasted corporate
assets, and that the officer defendants engaged in insider trading in violation
of California law. The plaintiffs sought to recover unspecified money
damages, disgorgement of profits and benefits, restitution, rescission of option
contracts, imposition of a constructive trust over option contracts, and
attorneys’ fees and costs. Following a hearing on July 13, 2007, the
Court sustained the Company’s demurrer, and granted the plaintiffs leave to
amend the complaint. The Court did not address the individual
defendants’ demurrer.
On August
13, 2007, the California plaintiffs filed an amended complaint, asserting claims
against the individual defendants for breaching, and aiding and abetting
breaches of fiduciary duty in connection with the grant of allegedly
“spring-loaded” and “bullet-dodged” stock options during the period from 1995
through 2005. The amended complaint also alleged that the individual
defendants were unjustly enriched, and engaged in insider trading in violation
of the California Corporations Code, and that the director defendants wasted
corporate assets. The amended complaint sought recovery from the
individual defendants of unspecified damages, disgorgement of profits and
benefits, restitution, rescission of option contracts and imposition of a
constructive trust over executory option contracts, in addition to attorneys’
fees and costs. On September 12, 2007, the Company filed a demurrer
to the amended complaint on the ground that the plaintiffs had failed to make a
pre-suit demand or to demonstrate that such a demand would have been
futile. The individual defendants filed demurrers on the ground that
the amended complaint failed to state a cause of action as to each of
them. Before the demurrers were fully briefed, the parties stipulated
to stay the California State Action pending the resolution of the motion to
dismiss the complaint in the Delaware Action. On March 7, 2008, the
Delaware Chancery Court denied defendants’ motion.
On May 5,
2008, the individual defendants moved to stay the California State Action;
Linear joined in that motion. That same day, plaintiffs moved to
coordinate discovery in the California State Action and the Delaware
Action. The individual defendants opposed that motion and Linear
joined in their opposition. In a June 18, 2008 order, the Court
granted the motion to stay the California State Action, and rejected, in part,
the plaintiffs’ request to coordinate discovery. The Court ordered
the defendants to supply the California plaintiffs with copies of documents
produced and transcripts of depositions conducted in the Delaware
Action. The Court is continuing to monitor the progress of the
Delaware Action. A case management conference is scheduled for
December 18, 2009.
In the
Delaware Action, filed on March 23, 2007, the plaintiff alleges that the
defendant directors breached their duty by granting “spring-loaded” and
“bullet-dodged” stock options to certain of the Company’s officers and directors
during the period from 1996 through 2005. The plaintiff also asserts
claims for unjust enrichment against those defendants who received the
challenged option grants. The plaintiff seeks to recover unspecified money
damages, disgorgement of profits and benefits, restitution, rescission of
certain defendants’ option contracts, imposition of a constructive trust over
the option contracts, and attorneys’ fees and costs. The defendants
moved to dismiss the Delaware Action on May 25, 2007. Rather than
respond to the motions, the plaintiff filed an amended complaint on August 10,
2007, making substantially the same allegations as those in the original
complaint. On September 19, 2007, the Company and the individual
defendants filed a Motion to Dismiss the amended complaint on the grounds that
the plaintiff had failed to make a pre-suit demand on the Board or to plead
facts demonstrating that such a demand would have been futile, and that the
amended complaint failed to state a claim against each of the individual
defendants. On March 7, 2008, the Court denied the
motion. Linear answered the amended complaint on April 7,
2008. Fact discovery concluded on July 1, 2009. Expert
discovery is currently scheduled to conclude on February 22, 2010. No
trial date has been set.
15
Item
2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations
Overview
Linear
Technology Corporation is a manufacturer of high performance linear integrated
circuits. The Company generates revenue exclusively from the sale of
analog integrated circuits. The Company targets the high performance
segment of the analog integrated circuit market. The Company was founded in 1981
and became a public company in 1986. Linear Technology products
include high performance amplifiers, comparators, voltage references, monolithic
filters, linear regulators, DC-DC converters, battery chargers, data converters,
communications interface circuits, RF signal conditioning circuits, uModuleTM
products, and many other analog functions. Applications for Linear
Technology’s high performance circuits include telecommunications, cellular
telephones, networking products such as optical switches, notebook and desktop
computers, computer peripherals, video/multimedia, industrial instrumentation,
security monitoring devices, high-end consumer products such as digital cameras
and MP3 players, complex medical devices, automotive electronics, factory
automation, process control, and military and space systems.
First
quarter revenue of $236.1 million increased $28.1 million or 14% over the fourth
quarter of fiscal year 2009 and decreased 24% or $74.2 million from $310.4
million reported in the first quarter of fiscal year 2009. Net income
of $60.7 million increased $9.3 million or 18% over the fourth quarter of fiscal
year 2009 and decreased $41.6 million or 41% from the first quarter of fiscal
year 2009 which in addition to higher revenue had a lower tax rate of 24%
compared to 28% this quarter. Diluted earnings per share (“EPS”)
increased $0.04 cents per share over the adjusted fourth quarter fiscal year
2009 results. Diluted EPS of $0.27 in the first quarter of fiscal
year 2010 was impacted negatively by approximately $0.025 cents per share due to
the adoption of two new accounting standards. For a further
discussion of the newly adopted accounting standards see Note 1 to the
consolidated financial statements, included in Part 1, “Financial
Information.” The Company retrospectively adopted the new accounting
standards, which adjusted the first quarter of fiscal year 2009 results. The
Company achieved both strong sequential quarterly revenue and profit growth;
however, on a year-over-year basis the Company’s results were down as the
Company continues to feel the effects of the global recession.
Critical
Accounting Estimates
There
have been no significant changes to the Company’s critical accounting policies
during the quarter ended September 27, 2009, as compared to the previous
disclosures in Management’s Discussion and Analysis of Financial Condition and
Results of Operations included in the Company’s Annual Report on Form 10-K for
the fiscal year ended June 28, 2009.
Results
of Operations
The table
below summarizes the income statement items for the three months ended September
27, 2009 and September 28, 2008 as a percentage of total revenue and provides
the percentage change in absolute dollars of such items comparing the interim
period ended September 27, 2009 to the corresponding period from the prior
fiscal year:
Three
Months Ended
|
|||||||
September
27,
|
September
28,
|
Increase/
|
|||||
2009
|
2008*
|
(Decrease)
|
|||||
Revenues
|
100.0%
|
100.0%
|
(24%)
|
||||
Cost
of sales
|
25.2
|
23.0
|
(17)
|
||||
Gross
profit
|
74.8
|
77.0
|
(26)
|
||||
Expenses:
|
|||||||
Research
and development
|
19.2
|
16.4
|
(11)
|
||||
Selling,
general and
|
|||||||
administrative
|
13.4
|
12.0
|
(15)
|
||||
32.6
|
28.4
|
(13)
|
|||||
Operating
income
|
42.2
|
48.6
|
(34)
|
||||
Interest
expense
|
(8.1)
|
(7.3)
|
(16)
|
||||
Interest
income
|
1.6
|
2.2
|
(45)
|
||||
Income
before
|
|||||||
income taxes
|
35.7%
|
43.6%
|
(38)
|
||||
Effective
tax rates
|
28.0%
|
24.3%
|
|||||
* As
adjusted for the adoption of ASC 470-20-10 to 35 (see Note 1 to the
consolidated financial statements, included in Part 1, “Financial
Information”).
16
Revenue
for the quarter ended September 27, 2009 was $236.1 million, a decrease of $74.2
million or 24% from revenue of $310.4 million for the same quarter of the
previous fiscal year. The decrease in revenue was due to lower
domestic and international sales as a result of the global
recession. The average selling price (“ASP”) of $1.49 per unit in the
first quarter of fiscal year 2010 was relatively flat as compared to the first
quarter of fiscal year 2009 ASP of $1.47 per unit. Geographically,
international revenues were $166.9 million or 71% of revenues, a decrease of
$59.3 million as compared to international revenues of $226.2 million or 73% of
revenues for the same quarter of the previous fiscal
year. Internationally, revenues to Rest of the World, which is
primarily Asia excluding Japan, represented $94.7 million or 40% of revenues,
while sales to Europe and Japan were $36.5 million or 16% of revenues and $35.7
million or 15% of revenues, respectively. Domestic revenues were
$69.2 million or 29% of revenues in the first quarter of fiscal year 2010, a
decrease of $15.0 million from $84.2 million or 27% of revenues in the same
period in fiscal year 2009.
Gross
profit of $176.6 million for the quarter ended September 27, 2009 decreased
$62.3 million or 26% from the gross profit of $238.9 million in the first
quarter of fiscal year 2009. Gross profit as a percentage of revenues
decreased to 74.8% in the first quarter of fiscal year 2010 as compared to 77.0%
for the same period in the previous fiscal year. The decrease in
gross profit as a percentage of revenues for the quarter ended September 27,
2009 was primarily due to spreading fixed costs over a lower sales
base.
Research
and development (“R&D”) expenses for the quarter ended September 27, 2009
were $45.3 million, a decrease of $5.5 million or 11% from R&D expenses of
$50.9 million for the same period in the previous fiscal year. The
decrease in R&D expenses was primarily due to a $4.0 million decrease in
compensation costs related to the reduction in workforce that occurred in the
second and fourth quarters of fiscal year 2009 and the 10% temporary reduction
in base pay that occurred during the fourth quarter of fiscal year
2009. The decrease in R&D was also due to a $2.5 million decrease
in the employee profit sharing accrual and a $0.7 million decrease in other
R&D expenses such as mask costs. Partially offsetting these
decreases to R&D expense was a $1.7 million increase in stock-based
compensation.
Selling,
general and administrative expenses (“SG&A”) for the quarter ended September
27, 2009 were $31.7 million, a decrease of $5.4 million or 15% from SG&A
expenses of $37.1 million for the same period in the previous fiscal
year. The decrease in SG&A expenses was primarily due to a $1.8
million decrease in the employee profit sharing accrual and a $1.8 million
decrease in compensation costs related to the reduction in workforce that
occurred in the second and fourth quarters of fiscal year 2009 and the 10%
temporary reduction in base pay that occurred during the fourth quarter of
fiscal year 2009. The decrease in SG&A expenses was also due to a
$2.8 million decrease in other SG&A expenses such as advertising and legal
costs. Partially offsetting these decreases to SG&A expense was a
$1.0 million increase in stock-based compensation.
Interest
expense of $19.1 million for the quarter ended September 27, 2009 decreased $3.6
million from the adjusted amount in the corresponding period of fiscal year
2009. The decrease in interest expense was primarily due to the
retirement of $304.2 million principal amount of the Company’s 3.125%
Convertible Senior Notes during fiscal year 2009 and the first quarter of fiscal
year 2010.
Interest
income of $3.9 million for the quarter ended September 27, 2009 decreased $3.1
million from the corresponding period of fiscal year 2009. Interest
income decreased due to a decrease in the average interest rate earned on the
Company’s cash, cash equivalents and marketable securities balances. In
addition, the Company’s cash, cash equivalents and marketable securities
balances decreased as the Company used its excess cash reserves to purchase
$304.2 million principal amount of the Company’s 3.125% Convertible Senior Notes
during fiscal year 2009 and the first quarter of fiscal year 2010.
The
Company’s tax rate for the first quarter of fiscal year 2010 was 28% as compared
to the adjusted rate of 24.3% in the same quarter of fiscal year
2009. The increase in the tax rate was primarily due to a quarterly
discrete tax benefit totaling $6.7 million recognized during the first quarter
of fiscal year 2009, primarily related to an IRS settlement and the related
reversal of liabilities for uncertain tax positions. The impact of
this quarterly discrete tax benefit was partially offset by a higher R&D
credit in the first quarter of fiscal year 2010 as the first quarter of fiscal
year 2009 included no tax benefit for the R&D credit as this credit had
expired and was not reinstated until the second quarter of fiscal year
2009.
The
Company’s effective tax rate is lower than the federal statutory rate of 35% as
a result of lower tax rates on the earnings of its wholly-owned foreign
subsidiaries, principally in Singapore and Malaysia. The Company has
a partial tax holiday through July 2015 in Malaysia and a partial tax holiday in
Singapore through August 2011. In addition, the Company receives tax benefits
from non-taxable interest income, domestic manufacturing and R&D tax
credits
Factors
Affecting Future Operating Results
Except
for historical information contained herein, the matters set forth in this Form
10-Q, including the statements in the following paragraphs, are forward-looking
statements that are dependent on certain risks and uncertainties including such
factors, among others, as the timing, volume and pricing of new orders received
and shipped during the quarter, the timely introduction of new processes and
products; increases in costs associated with utilities, transportation and raw
materials; currency fluctuations; the effects of adverse economic conditions in
the United States and international markets and other factors described below
and in “Item 1A – Risk Factors” section of this Quarterly Report on
Form 10-Q.
17
The
quarter ended September 27, 2009 had strong revenue and profit growth over the
fourth quarter of fiscal year 2009. The Company saw improvements in customer
orders during the latter half of the quarter in each of its end-markets except
the cell phone end-market. In particular, the Company saw
improvements in the automotive and industrial end-markets. As a result, revenues
significantly improved over the previous quarter as sales grew 14% and operating
income grew by 26% representing 42% of sales as of the quarter ended September
27, 2009.
Notwithstanding
the high rate of growth the Company achieved over the fourth quarter of fiscal
year 2009, there is still some uncertainty looking ahead to the second quarter
of fiscal year 2010. The financial effects of the global recession
are certainly not over and continue to impact many of the Company’s
customers. Customer orders continue to call for short lead times and
turns business, or bookings that are recorded and shipped during the quarter,
remains at a high level. While there are some concerns that recent improvements
in the overall marketplace are at least partially attributable to a
replenishment of inventory stock, the Company continues to experience bookings
improvement. Therefore, based upon our positive book to bill ratio and the
strength of the recovery the Company appears to be witnessing in its automotive
and industrial end-markets, the Company expects revenue to grow 2% to 5% over
the first quarter of fiscal year 2010.
Although
the Company believes that it has the product lines, manufacturing facilities and
technical and financial resources for its current operations, sales and
profitability could be significantly affected by factors described above and
other factors. Additionally, the Company’s common stock could be
subject to significant price volatility should sales and/or earnings fail to
meet expectations of the investment community. Furthermore, stocks of high
technology companies are subject to extreme price and volume fluctuations that
are often unrelated or disproportionate to the operating performance of these
companies.
Liquidity
and Capital Resources
At
September 27, 2009, the Company’s cash, cash equivalents and marketable
securities balances were $909.5 million in aggregate, representing an increase
of $40.7 million over the June 28, 2009 balances of $868.7 million. This
increase was primarily due to positive cashflow from operations of $108.1
million. Working capital as of September 27, 2009 was $993.4
million. During the first quarter of fiscal year 2010, significant
cash expenditures included $11.3 million for the net purchase of
available-for-sale securities; $3.4 million for capital additions; $9.8 million
face value to purchase and retire a portion of the 3.125% Convertible Senior
Notes; $4.2 million to purchase its common stock and $49.9 million for the
payment of a cash dividend, representing $0.22 per share in the first quarter of
fiscal year 2010.
Accounts
receivable totaled $113.2 million at the end of the first quarter of fiscal year
2010, an increase of $17.8 million from the end of the fourth quarter of fiscal
year 2009. The increase is primarily due to higher shipments in the
first quarter of fiscal year 2010 as compared to the fourth quarter of fiscal
year 2009. Inventory totaled $49.3 million at the end of the first quarter of
fiscal year 2010, a decrease of $3.1 million from the end of the fourth quarter
of fiscal year 2009. The decrease was due to higher sales in the first quarter
of fiscal year 2010 as compared to the fourth quarter of fiscal year
2009.
Accrued
payroll and related benefits decreased $3.7 million from the fourth quarter of
fiscal year 2009 primarily due to the payment of profit sharing partially offset
by an increase to the profit sharing accrual and increases in other payroll
liabilities. The Company accrues for profit sharing on a quarterly
basis while distributing payouts to employees on a semi-annual basis during the
first and third quarters of each fiscal year. Income taxes payable
for the first quarter of fiscal year 2010 increased $17.9 million over the
fourth quarter of fiscal year 2009 primarily due to the income tax provision of
$23.6 million. Other accrued liabilities of $44.4 million increased
$12.0 million over the fourth quarter of fiscal year 2009 primarily due to
accrued interest on the Company’s Convertible Senior Notes. The
Company makes semi-annual interest payments during the second and fourth
quarters of each fiscal year.
In
October 2009, the Company’s Board of Directors declared a cash dividend of $0.22
per share. The $0.22 per share dividend will be paid on November 25,
2009 to shareholders of record on November 13, 2009. The payment of
future dividends will be based on the Company’s financial
performance.
Historically,
the Company has satisfied its liquidity needs through cash generated from
operations. Given its financial condition and historical operating
performance, the Company believes that current capital resources and cash
generated from operating activities will be sufficient to meet its liquidity,
capital expenditures requirements, and debt retirement for the near
future.
Off
Balance-Sheet Arrangements
As of
September 27, 2009, the Company had no off-balance sheet financing
arrangements.
18
Contractual
Obligations
In April
2007, the Company issued $1.0 billion principal amount of 3.0% debentures due
May 1, 2027 and $0.7 billion principal amount of 3.125% debentures due May 1,
2027. Through the first quarter of fiscal year 2010, the Company
purchased and retired $304.2 million face value of its 3.125% Convertible Senior
Notes. The Company pays cash interest at an annual rate of 3.0% and
3.125%, respectively, payable semiannually on November 1 and May 1 of each year,
beginning November 1, 2007. See Note 8 to the consolidated financial statements,
included in Part 1, “Financial Information,” for additional information about
the debentures.
Fair
Value
As of
September 27, 2009, the Company’s cash and cash equivalents, and marketable
securities investment portfolio had a fair value of $807.1
million. The Company’s cash and cash equivalents, and marketable
securities investment portfolio consists of money-market funds, U.S. Treasury
securities, obligations of U.S. government-sponsored enterprises, municipal
bonds, commercial debt and corporate debt securities. The Company
currently does not hold any investments in auction rate securities or asset
backed securities. Most of the Company’s investments in debt
instruments have an investment rating of AAA. As of September 27,
2009, the Company’s cash and cash equivalents, and marketable securities
investment portfolio had a remaining maturity of approximately one
year. As of September 27, 2009, the Company’s financial instruments
measured at fair value totaled $807.1 million and were classified as Level 1 or
Level 2 instruments.
Item
3. Quantitative and Qualitative Disclosures About
Market Risk
For
additional quantitative and qualitative disclosures about market risk affecting
the Company, see item 7A of the Company’s Form 10-K for the fiscal year ended
June 28, 2009. There have been no material changes in the market risk
affecting the Company since the filing of the Company’s Form 10-K for fiscal
year 2009. At September 27, 2009, the Company’s cash and cash
equivalents, and marketable securities consisted of money-market funds, U.S.
Treasury securities, obligations of U.S. government sponsored enterprises,
municipal bonds, commercial debt and corporate debt securities. The Company did
not hold any derivative financial instruments. The Company’s interest income is
sensitive to changes in the general level of interest rates. In this regard,
changes in interest rates can affect the interest earned on cash and cash
equivalents and short-term investments.
The
Company’s revenues outside the United States are transacted in U.S. dollars;
accordingly the Company’s revenues are not impacted by foreign currency rate
changes. To date, fluctuations in foreign currency exchange rates
have not had a material impact on the results of operations.
Item
4. Controls and Procedures
(a)Evaluation of Disclosure Controls
and Procedures.
The
Company’s management, with the participation of its Chief Executive Officer and
Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure
controls and procedures as of the end of the period covered by this Quarterly
Report on Form 10-Q. For purposes of this section, the term disclosure controls and
procedures means controls and other procedures of an issuer that are
designed to ensure that information required to be disclosed by the issuer in
the reports that it files or submits under the Securities Exchange Act of 1934
(15 U.S.C. 78a et seq.)
is recorded, processed, summarized and reported within the time periods
specified in the Commission's rules and forms. Disclosure controls
and procedures include, without limitation, controls and procedures designed to
ensure that information required to be disclosed by an issuer in the reports
that it files or submits under the Securities Exchange Act of 1934 is
accumulated and communicated to the issuer's management, including its principal
executive and principal financial officers, or persons performing similar
functions, as appropriate to allow timely decisions regarding required
disclosure.
The
Company’s management evaluated, with the participation of its Chief Executive
Officer and Chief Financial Officer, the effectiveness of the Company’s
disclosure controls and procedures for the quarter ended September 27,
2009. Based on this evaluation, the Company’s Chief Executive Officer
and Chief Financial Officer have concluded that the Company’s disclosure
controls and procedures are effective to ensure that information it is required
to disclose in reports that it files or submits under the Securities Exchange
Act of 1934 is accumulated and communicated to the Company’s management,
including its principal executive and principal financial officers, as
appropriate to allow timely decisions regarding required disclosure, and that
such information is recorded, processed, summarized and reported within the time
periods specified in Securities and Exchange Commission rules and
forms.
19
(b)Changes in Internal Control over
Financial Reporting.
No change
in the Company’s internal control over financial reporting (as defined in
Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934)
occurred during the quarter ended September 27, 2009 that has materially
affected, or is reasonably likely to materially affect, the Company’s internal
control over financial reporting.
PART
II. OTHER
INFORMATION
Item
1.
|
Legal
Proceedings
|
The
Company is subject to various legal proceedings and claims that arise in the
ordinary course of business on a wide range of matters, including, among others,
patent suits and employment claims. The Company does not believe that
any such current suits will have a material impact on its business or financial
condition. However, current lawsuits and any future lawsuits will
divert resources and could result in the payment of substantial
damages.
Certain
current and former directors and officers of the Company have been named as
defendants in two shareholder derivative actions filed in the United States
District Court for the Northern District of California, which have been
consolidated under the caption In re Linear Technology Corporation
Shareholder Derivative Litigation (the “Federal Action”), in three
consolidated shareholder derivative actions filed in the Superior Court for
Santa Clara County, California, also captioned In re Linear Technology Corporation
Shareholder Derivative Litigation (the “California State Action”), and in
a shareholder derivative action filed in Delaware Chancery Court, captioned
Weiss v. Swanson (the
“Delaware Action”). The Company has been named in each of these
Actions as a nominal defendant against which no recovery is sought.
In the
Federal Action, the plaintiffs alleged that the individual defendants breached
their fiduciary duties to the Company in connection with the alleged backdating
of stock option grants during the period from 1995 through 2002, and asserted
derivative claims against the individual defendants based on alleged violations
of Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”)
and Rule 10b-5 promulgated thereunder. On December 7, 2006, the Court
granted Linear’s motion to dismiss the complaint for failure to make a pre-suit
demand or to demonstrate that such a demand would have been
futile. The plaintiffs filed an amended complaint on January 5, 2007
asserting derivative claims against the individual defendants for alleged
violations of Sections 10(b), 14(a), and 20(a) of the Exchange Act, and Rules
10b-5 and 14a-9 promulgated thereunder. Pursuant to the parties’
stipulation, on February 14, 2007, the District Court entered an order staying
the Federal Action in favor of permitting the California State Action to
proceed.
In the
California State Action, the plaintiffs initially asserted claims against the
individual defendants for breaching, and aiding and abetting breaches of,
fiduciary duty in connection with the alleged backdating of stock option grants
during the period from 1995 through 2002. The plaintiffs also alleged
that certain defendants were unjustly enriched, that defendants wasted corporate
assets, and that the officer defendants engaged in insider trading in violation
of California law. The plaintiffs sought to recover unspecified money
damages, disgorgement of profits and benefits, restitution, rescission of option
contracts, imposition of a constructive trust over option contracts, and
attorneys’ fees and costs. Following a hearing on July 13, 2007, the
Court sustained the Company’s demurrer, and granted the plaintiffs leave to
amend the complaint. The Court did not address the individual
defendants’ demurrer.
On August
13, 2007, the California plaintiffs filed an amended complaint, asserting claims
against the individual defendants for breaching, and aiding and abetting
breaches of fiduciary duty in connection with the grant of allegedly
“spring-loaded” and “bullet-dodged” stock options during the period from 1995
through 2005. The amended complaint also alleged that the individual
defendants were unjustly enriched, and engaged in insider trading in violation
of the California Corporations Code, and that the director defendants wasted
corporate assets. The amended complaint sought recovery from the
individual defendants of unspecified damages, disgorgement of profits and
benefits, restitution, rescission of option contracts and imposition of a
constructive trust over executory option contracts, in addition to attorneys’
fees and costs. On September 12, 2007, the Company filed a demurrer
to the amended complaint on the ground that the plaintiffs had failed to make a
pre-suit demand or to demonstrate that such a demand would have been
futile. The individual defendants filed demurrers on the ground that
the amended complaint failed to state a cause of action as to each of
them. Before the demurrers were fully briefed, the parties stipulated
to stay the California State Action pending the resolution of the motion to
dismiss the complaint in the Delaware Action. On March 7, 2008, the
Delaware Chancery Court denied defendants’ motion.
On May 5,
2008, the individual defendants moved to stay the California State Action;
Linear joined in that motion. That same day, plaintiffs moved to
coordinate discovery in the California State Action and the Delaware
Action. The individual defendants opposed that motion and Linear
joined in their opposition. In a June 18, 2008 order, the Court
granted the motion to stay the California State Action, and rejected, in part,
the plaintiffs’ request to coordinate discovery. The Court ordered
the defendants to supply the California plaintiffs with copies of documents
produced and transcripts of depositions conducted in the Delaware
Action. The Court is continuing to monitor the progress of the
Delaware Action. A case management conference is scheduled for
December 18, 2009.
20
In the
Delaware Action, filed on March 23, 2007, the plaintiff alleges that the
defendant directors breached their duty by granting “spring-loaded” and
“bullet-dodged” stock options to certain of the Company’s officers and directors
during the period from 1996 through 2005. The plaintiff also asserts
claims for unjust enrichment against those defendants who received the
challenged option grants. The plaintiff seeks to recover unspecified money
damages, disgorgement of profits and benefits, restitution, rescission of
certain defendants’ option contracts, imposition of a constructive trust over
the option contracts, and attorneys’ fees and costs. The defendants
moved to dismiss the Delaware Action on May 25, 2007. Rather than
respond to the motions, the plaintiff filed an amended complaint on August 10,
2007, making substantially the same allegations as those in the original
complaint. On September 19, 2007, the Company and the individual
defendants filed a Motion to Dismiss the amended complaint on the grounds that
the plaintiff had failed to make a pre-suit demand on the Board or to plead
facts demonstrating that such a demand would have been futile, and that the
amended complaint failed to state a claim against each of the individual
defendants. On March 7, 2008, the Court denied the
motion. Linear answered the amended complaint on April 7,
2008. Fact discovery concluded on July 1, 2009. Expert
discovery is currently scheduled to conclude on February 22, 2010. No
trial date has been set.
Item
1A.
|
Risk
Factors
|
A description of the risk factors
associated with the Company’s business is set forth below. In addition to the
risk factors discussed below, see “Factors Affecting Future Operating Results”
included in “Management's Discussion and Analysis” for further discussion of
other risks and uncertainties that may affect the Company.
Reduced
consumer and/or corporate spending due to uncertainties in the macroeconomic
environment could further adversely affect our revenues and
profitability.
We depend
on demand from the industrial, communication, computer, consumer and automotive
end-markets we serve. Our revenues and profitability are based on certain levels
of consumer and corporate spending. Reductions in consumer and/or corporate
spending as a result of uncertain conditions in the macroeconomic environment,
such as global credit conditions, mortgage failures, fluctuations in interest
rates, higher energy prices, or otherwise, have adversely affected, and may
continue to adversely affect, our revenues and profitability. These uncertain
conditions may persist or worsen in fiscal year 2010.
Downturns
in the business cycle could adversely affect our revenues and
profitability.
The
semiconductor market has historically been cyclical and subject to significant
economic downturns at various times. The cyclical nature of the
semiconductor industry may cause us to experience substantial period-to-period
fluctuations in our results of operations. The growth rate of the
global economy is one of the factors affecting demand for semiconductor
components. Many factors could adversely affect regional or global
economic growth including turmoil or depressed conditions in financial or credit
markets, depressed business or consumer confidence, increased unemployment,
increased price inflation for goods, services or materials, rising interest
rates in the United States and the rest of the world, a significant act of
terrorism which disrupts global trade or consumer confidence, geopolitical
tensions including war and civil unrest, reduced levels of economic activity, or
disruptions of international transportation. The Company’s third and
fourth quarters of fiscal year 2009 had significant year-over-year revenues
declines of over 30% due to the present economic downturn.
Typically,
our ability to meet our revenue goals and projections is dependent to a large
extent on the orders we receive from our customers within the period and by our
ability to match inventory and current production mix with the product mix
required to fulfill orders on hand and orders received within a period for
delivery in that period. Because of this complexity in our business,
no assurance can be given that we will achieve a match of inventory on hand,
production units, and shippable orders sufficient to realize quarterly or annual
revenue and net income goals.
Volatility
in customer demand in the semiconductor industry could affect future levels of
sales and profitability and limit our ability to predict such
levels.
Historically,
we have maintained low lead times, which has enabled customers to place orders
close to their true needs for product. In defining our financial goals and
projections, we consider inventory on hand, backlog, production cycles and
expected order patterns from customers. If our estimates in these
areas become inaccurate, we may not be able to meet our revenue goals and
projections. In addition, some customers require us to manufacture
product and have it available for shipment, even though the customer is
unwilling to make a binding commitment to purchase all, or even some, of the
products. As a result, in any quarterly fiscal period we are subject
to the risk of cancellation of orders leading to a fall-off of sales and
backlog. Further, those orders may be for products that meet the
customer’s unique requirements so that those cancelled orders would, in
addition, result in an inventory of unsaleable products, and thus potential
inventory write-offs. We routinely estimate inventory reserves
required for such products, but actual results may differ from these reserve
estimates.
21
We
generate revenue from thousands of customers worldwide and our revenues are
diversified by end-market and geographical region. Our results in any
period, or sequence of periods, may be positively affected by the fact that a
customer has designed one of our products into one of their high selling
products. This positive effect may not last, however, as our
customers frequently redesign their high selling products, especially to lower
their products’ costs. In such redesigns, they may decide to no
longer use our product or may seek pricing terms from us that we choose not to
accede to, thus resulting in the customer ceasing or significantly decreasing
its purchases from us. The loss of, or a significant reduction in
purchases by a portion of our customer base, for this or other reasons, such as
changes in purchasing practices, could adversely affect our results of
operations. In addition, the timing of customers’ inventory
adjustments may adversely affect our results of operations.
We
may be unsuccessful in developing and selling new products required to maintain
or expand our business.
The
markets for our products depend on continued demand for our products in the
communications, industrial, computer, high-end consumer and automotive
end-markets. The semiconductor industry is characterized by rapid technological
change, variations in manufacturing efficiencies of new products, and
significant expenditures for capital equipment and product
development. New product offerings by competitors and customer
demands for increasing linear integrated circuit performance or lower prices may
render Linear’s products less competitive over time, thus necessitating
continual development of new products by Linear. New product
introductions are thus a critical factor for maintaining or increasing future
sales growth and sustained or increased profitability, but they can present
significant business challenges because product development commitments and
expenditures must be made well in advance of the related
revenues. The success of a new product depends on a variety of
factors including accurate forecasts of long-term market demand and future
technological developments, accurate anticipation of competitors’ actions and
offerings, timely and efficient completion of process design and development,
timely and efficient implementation of manufacturing and assembly processes,
product performance, quality and reliability of the product, and effective
marketing, sales and service.
Although
we believe that the high performance segment of the linear integrated circuit
market is generally less affected by price erosion or by significant
expenditures for capital equipment and product development than other
semiconductor market sectors, future operating results may reflect substantial
period-to-period fluctuations due to these or other factors.
Our
manufacturing operations may be interrupted or suffer yield
problems.
We rely
on our internal manufacturing facilities located in California and Washington to
fabricate most of our wafers, we depend on outside silicon foundries for a small
portion (less than 5%) of our wafer fabrication. We could be adversely affected
in the event of a major earthquake, which could cause temporary loss of
capacity, loss of raw materials, and damage to manufacturing
equipment. Additionally, we rely on our internal and external
assembly and testing facilities located in Singapore and Malaysia. We
are subject to economic and political risks inherent to international
operations, including changes in local governmental policies, currency
fluctuations, transportation delays and the imposition of export controls or
increased import tariffs. We could be adversely affected if any such changes are
applicable to our foreign operations.
Our
manufacturing yields are a function of product design and process technology,
both of which are developed by us. The manufacture and design of
integrated circuits is highly complex. We may experience
manufacturing problems in achieving acceptable yields or experience product
delivery delays in the future as a result of, among other things, capacity
constraints, equipment malfunctioning, construction delays, upgrading or
expanding existing facilities or changing our process technologies, any of which
could result in a loss of future revenues or increases in fixed
costs. To the extent we do not achieve acceptable manufacturing
yields or there are delays in wafer fabrication, our results of operations could
be adversely affected. In addition, operating expenses related to
increases in production capacity may adversely affect our operating results if
revenues do not increase proportionately.
Our
dependence on third party foundries and other manufacturing subcontractors may
cause delays beyond our control in delivering our products to our
customers.
A portion
of our wafers (approximately 5% to 15%) are processed offshore by independent
assembly subcontractors located in Malaysia and Thailand. These
subcontractors separate wafers into individual circuits and assemble them into
various finished package types. Reliability problems experienced by
our assemblers could cause problems in delivery and quality, resulting in
potential product liability to us. We could also be adversely
affected by political disorders, labor disruptions, and natural disasters in
these locations.
22
We are
dependent on outside silicon foundries for a small portion (less than 5%) of our
wafer fabrication. As a result, we cannot directly control delivery
schedules for these products, which could lead to product shortages, quality
assurance problems and increases in the cost of our products. We may
experience delays in delivering our products to our customers. If
these foundries are unable or unwilling to produce adequate supplies of
processed wafers conforming to our quality standards, our business and
relationships with our customers for the limited quantities of products produced
by these foundries could be adversely affected. Finding alternate
sources of supply or initiating internal wafer processing for these products may
not be economically feasible. In addition, the manufacture of our
products is a highly complex and precise process, requiring production in a
highly controlled environment. Changes in manufacturing processes or
the inadvertent use of defective or contaminated materials by a third party
foundry could adversely affect the foundry’s ability to achieve acceptable
manufacturing yields and product reliability.
We
rely on third party suppliers for materials, supplies, and subcontract services
that may not have adequate capacity to meet our product delivery
requirements.
The
semiconductor industry has experienced a very large expansion of fabrication
capacity and production worldwide over time. As a result of increasing demand
from semiconductor and other manufacturers, availability of certain basic
materials and supplies, such as chemicals, gases, polysilicon, silicon wafers,
ultra-pure metals, lead frames and molding compounds, and of subcontract
services, like epitaxial growth, ion implantation and assembly of integrated
circuits into packages, have from time to time, over the past several years,
been in short supply and could come into short supply again if overall industry
demand continues to increase in the future. In addition, from time to time
natural disasters can lead to a shortage of some of the above materials due to
disruption of the manufacturer’s production. We do not have long-term
agreements providing for all of these materials, supplies, and services, and
shortages could occur as a result of capacity limitations or production
constraints on suppliers that could have a materially adverse effect on our
ability to achieve our planned production.
A number
of our products use components that are purchased from third
parties. Supplies of these components may not be sufficient to meet
all customer requested delivery dates for products containing the components,
which could adversely affect future sales and earnings. Additionally,
significant fluctuations in the purchase price for these components could affect
gross margins for the products involved. Suppliers could also
discontinue the manufacture of such purchased products or could have quality
problems that could affect our ability to meet customer
commitments. In addition, suppliers of semiconductor manufacturing
equipment are sometimes unable to deliver test and/or fabrication equipment to a
schedule or equipment performance specification that meets our
requirements. Delays in delivery of equipment needed for growth could
adversely affect our ability to achieve our manufacturing and revenue plans in
the future.
We
are exposed to business, economic, political and other risks through our
significant worldwide operations.
During
the first quarter of fiscal year 2010, 71% of our revenues were derived from
customers in international markets. Also, the Company has test and assembly
facilities in Singapore and Malaysia. Accordingly, we are subject to the
economic and political risks inherent in international sales and operations and
their impact on the United States economy in general, including the risks
associated with ongoing uncertainties and political and economic instability in
many countries around the world as well as the economic disruption from
financial and economic declines or turmoil, dysfunction in the credit markets,
acts of terrorism, or the response to any of the foregoing by the United States
and other major countries.
We
are a party to private litigation related to our historical stock option
granting practices, in which an unfavorable outcome could have a
material adverse effect on our financial results for a particular period or the
trading price for our securities.
Several
lawsuits have been filed against current and former directors and officers
relating to our historical stock option granting practices. The
Company is named as a nominal defendant in those lawsuits. These
actions are in the preliminary stages, and their ultimate outcome could have a
material adverse effect on our results of operations or cash flows for a
particular period or the trading price for our securities. Litigation
is time-consuming, expensive and disruptive to our normal business operations,
and outcomes are difficult to predict. The defense of these lawsuits
has resulted and will continue to result in significant legal expenditures and
diversion of our management’s time and attention from business
operations. In addition, we have entered into indemnification
agreements with our current and former directors and officers, under which we
are required to indemnify those persons against expenses, including attorneys’
fees, judgments, fines and settlements, payable by them in connection with this
litigation, subject to applicable law. If we were required to pay any
amounts to satisfy a judgment or in settlement of any of these claims, these
amounts may not be covered by insurance.
For a
further discussion on legal matters see “Legal Proceedings” in Part
II, Item 1 of this Form 10-Q.
23
We
may be unable to adequately protect our proprietary rights, which may impact our
ability to compete effectively.
Our
success depends in part on our proprietary technology. While we attempt to
protect our proprietary technology through patents, copyrights and trade secret
protection, we believe that our success also depends on increasing our
technological expertise, continuing our development of new products and
providing comprehensive support and service to our
customers. However, we may be unable to protect our technology in all
instances, or our competitors may develop similar or more competitive technology
independently. We currently hold a number of United States and
foreign patents and pending patent applications. However, other
parties may challenge or attempt to invalidate or circumvent any patents the
United States or foreign governments issue to us or these governments may fail
to issue patents for pending applications. In addition, the rights
granted or anticipated under any of these patents or pending patent applications
may be narrower than we expect or, in fact provide no competitive
advantages. Furthermore, effective patent, trademark, copyright,
maskwork and trade secret protection may be unavailable, limited or not applied
for in certain foreign countries. We may incur significant legal costs to
protect our intellectual property.
We also
seek to protect our proprietary technology, including technology that may not be
patented or patentable, in part by confidentiality agreements and, if
applicable, inventors’ rights agreements with our collaborators, advisors,
employees and consultants. We cannot assure you that these agreements
will always be undertaken or will not be breached or that we will have adequate
remedies for any breach.
We have
received, and may receive in the future, notices of claims of infringement and
misappropriation of other parties’ proprietary rights. In the event
of an adverse decision in a patent, trademark, copyright, maskwork or trade
secret action, we could be required to withdraw the product or products found to
be infringing from the market or redesign products offered for sale or under
development. Whether or not these infringement claims are
successfully asserted, we would likely incur significant costs and diversion of
our resources with respect to the defense of these claims. In the
event of an adverse outcome in any litigation, we may be required to pay
substantial damages, including enhanced damages for willful infringement, and
incur significant attorneys’ fees, as well as indemnify customers for damages
they might suffer if the products they purchase from us infringe intellectual
property rights of others. We could also be required to stop our
manufacture, use, sale or importation of infringing products, expend significant
resources to develop or acquire non-infringing technology, discontinue the use
of some processes, or obtain licenses to intellectual property rights covering
products and technology that we may, or have been found to, infringe or
misappropriate such intellectual property rights.
Our
products may contain defects that could affect our results of
operations.
Our
products may contain undetected errors or defects. Such problems may
cause delays in product introductions and shipments, result in increased costs
and diversion of development resources, cause us to incur increased charges due
to obsolete or unusable inventory, require design modifications, or decrease
market acceptance or customer satisfaction with these products, which could
result in product returns. In addition, we may not find defects or
failures in our products until after commencement of commercial shipments, which
may result in loss or delay in market acceptance and could significantly harm
our operating results. Our current or potential customers also might
seek to recover from us any losses resulting from defects or failures in our
products; further, such claims might be significantly higher than the revenues
and profits we receive from our products involved as we are usually a component
supplier with limited value content relative to the value of a complete system
or sub-system. Liability claims could require us to spend significant
time and money in litigation or to pay significant damages for which we may have
insufficient insurance coverage. Any of these claims, whether or not
successful, could seriously damage our reputation and business.
If
we fail to attract and retain qualified personnel, our business may be
harmed.
Our
performance is substantially dependent on the performance of our executive
officers and key employees. The loss of the services of key officers,
technical personnel or other key employees could harm the
business. Our success depends on our ability to identify, hire,
train, develop and retain highly qualified technical and managerial
personnel. Failure to attract and retain the necessary technical and
managerial personnel could harm us.
We
may not be able to compete successfully in markets within the semiconductor
industry in the future.
We
compete in the high performance segment of the linear market. Our competitors
include among others, Analog Devices, Inc., Intersil, Maxim Integrated Products,
Inc., National Semiconductor Corporation and Texas Instruments, Inc. Competition
among manufacturers of linear integrated circuits is intense, and certain of our
competitors may have significantly greater financial, technical, manufacturing
and marketing resources than us. The principal elements of
competition include product performance, functional value, quality and
reliability, technical service and support, price, diversity of product line and
delivery capabilities. We believe we compete favorably with respect to these
factors, although we may be at a disadvantage in comparison to larger companies
with broader product lines and greater technical service and support
capabilities.
24
Environmental
liabilities could force us to expend significant capital and incur substantial
costs.
Federal,
state and local regulations impose various environmental controls on the
storage, use, discharge and disposal of certain chemicals and gases used in
semiconductor processing. Our facilities have been designed to comply
with these regulations, and we believe that our activities conform to present
environmental regulations. Increasing public attention has, however,
been focused on the environmental impact of electronics manufacturing
operations. While we to date have not experienced any materially
adverse business effects from environmental regulations, there can be no
assurance that changes in such regulations will not require us to acquire costly
remediation equipment or to incur substantial expenses to comply with such
regulations. Any failure by us to control the storage, use or
disposal of, or adequately restrict the discharge of hazardous substances could
subject us to significant liabilities.
Our
financial results may be adversely affected by increased tax rates and exposure
to additional tax liabilities.
As a
global company, our effective tax rate is highly dependent upon the geographic
composition of worldwide earnings and tax regulations governing each
region. We are subject to income taxes in both the United States and
various foreign jurisdictions, and significant judgment is required to determine
worldwide tax liabilities. Our effective tax rate as well as the
actual tax ultimately payable could be adversely affected by changes in the
split of earnings between countries with differing statutory tax rates, in the
valuation of deferred tax assets, in tax laws or by material audit assessments,
which could affect our profitability. In addition, the amount of
income taxes we pay is subject to ongoing audits in various jurisdictions, and a
material assessment by a governing tax authority could affect our profitability.
Finally, jurisdictions could change their tax regulations to include profits
that were previously exempt.
We
are leveraged, and our debt obligations may affect our business, operating
results and financial condition.
As of
September 27, 2009, we have debt outstanding of $1.0 billion aggregate principal
amount of our 3.00% Convertible Senior Notes due May 1, 2027 and $395.8 million
aggregate principal amount of our 3.125% Convertible Senior Notes due May 1,
2027 (collectively, the “Notes”). Debt service obligations arising
from the Notes could adversely affect us in a number of ways, including
by:
·
|
limiting
our ability to obtain in the future, if needed, financing for working
capital, capital expenditures, debt service requirements or other
corporate purposes;
|
·
|
limiting
our flexibility in implementing our business strategy and in planning for,
or reacting to, changes in our
business;
|
·
|
placing
us at a competitive disadvantage relative to any of our competitors who
have lower levels of debt;
|
·
|
decreasing
our debt ratings and increasing our cost of borrowed
funds;
|
·
|
making
us more vulnerable to a downturn in our business or the economy
generally;
|
·
|
subjecting
us to the risk of being forced to refinance at higher interest rates these
amounts when due; and
|
·
|
requiring
us to use a substantial portion of our cash to pay principal and interest
on our debt instead of contributing those funds to other purposes such as
working capital, capital expenditures or other corporate
purposes.
|
Our
stock price may be volatile.
The
trading price of our common stock may be subject to wide fluctuations. Our stock
price may fluctuate in response to a number of events and factors, such as
general United States and world economic and financial conditions, our own
quarterly variations in operating results, announcements of technological
innovations or new products by us or our competitors, changes in financial
estimates and recommendations by securities analysts, the operating and stock
price performance of other companies that investors may deem comparable to us,
the hedging of our common stock and other derivative transactions by third
parties, and new reports relating to trends in our markets or those of our
customers. Additionally, lack of positive performance in our stock
price may adversely affect our ability to retain key employees.
The stock
market in general, and prices for companies in our industry in particular, has
experienced extreme volatility that often has been unrelated to the operating
performance of a particular company. These broad market and industry
fluctuations may adversely affect the price of our common stock, regardless of
our operating performance. As our Notes are convertible into shares
of our common stock, volatility or depressed prices of our common stock could
have a similar effect on the trading price of our Notes. In addition,
to the extent we deliver common stock on conversion of the Notes, the ownership
interests of our existing stockholders may be diluted. Sales in the public
market of common stock issuable upon such conversion could adversely affect
prevailing market prices of our common stock, as could the anticipated
conversion of the Notes.
25
We may not have
the ability to repurchase the Notes or to pay cash upon their conversion if and
as required by the indentures governing the Notes.
Holders
of the Notes have the right to require us to repurchase, and we intend to
repurchase, the Notes for cash on specified dates or upon the occurrence of a
fundamental change. The first of these dates is November 1, 2010, at which time
we will be required to repurchase all of the outstanding $395.8 million (less
any amounts repurchased by us in the open market prior to such time) of our
3.125% Notes. However, we may not have sufficient funds to repurchase the Notes
in cash or to make the required repayment at such time or have the ability to
arrange necessary financing on acceptable terms. In addition, upon conversion of
the Notes we will be required to make cash payments to the holders of the Notes
equal to the lesser of the principal amount of the Notes being converted and the
conversion value of those Notes. Such payments could be significant,
and we may not have sufficient funds to make them at such time.
Our
failure to repurchase the Notes or convert the Notes into cash or a combination
of cash and shares upon exercise of a holder’s conversion right in accordance
with the provisions of the indentures would constitute a default under the
applicable indenture. In addition, a default under either indenture
could lead to a default under existing and future agreements governing our
indebtedness. If, due to a default, the repayment of the related
indebtedness were to be accelerated after any applicable notice or grace
periods, we may not have sufficient funds to repay such indebtedness and the
Notes.
A
fundamental change may also constitute an event of default under, or result in
the acceleration of the maturity of, our then-existing indebtedness. In
addition, our ability to repurchase the Notes in cash or make any other required
payments may be limited by law or the terms of other agreements relating to our
indebtedness outstanding at the time.
The
terms of the Notes and related provisions in the indentures subject noteholders
to risks. Noteholders should be aware of the following risks, in
addition to those described for holders of our common stock:
·
|
We
are not restricted from taking actions or incurring additional debt
(including secured debt) which may affect our ability to make payments
under the Notes;
|
·
|
The
Notes are not secured by any of our assets or those of our subsidiaries
and are effectively subordinated to any secured debt we may
incur. In any liquidation, dissolution, bankruptcy or other
similar proceeding, holders of our secured debt may assert rights against
any assets securing such debt in order to receive full payment of their
debt before those assets may be used to pay the holders of the Notes. In
such an event, we may not have sufficient assets remaining to pay amounts
due on any or all of the Notes. In addition, none of our
subsidiaries have guaranteed our obligations under, or have any obligation
to pay any amounts due on, the Notes. As a result, the Notes
are effectively subordinated to all liabilities of our subsidiaries,
including trade payables;
|
·
|
The
fundamental change provisions in the Notes and the indentures may not
require us to offer to repurchase the Notes in the event of certain
transactions. For example, any leveraged recapitalization,
refinancing, restructuring, or acquisition initiated by us will generally
not constitute a fundamental change requiring us to repurchase the
Notes;
|
·
|
The
liquidity of the trading market in the Notes, and the market price quoted
for these Notes, may be adversely affected by, among other things, changes
in, or other factors affecting, the market prices of our common stock,
changes in the overall market for debt securities, and prevailing interest
rates;
|
·
|
The
conversion rates of the Notes may not adjust for certain events, such as a
third-party tender or exchange offer or an issuance of our common stock
for cash. In addition, adjustments in conversion rates may not
adequately compensate noteholders for any lost value in the Notes as a
result of a particular transaction;
|
·
|
The
Notes may not be rated or may receive a lower rating than anticipated,
which may impact the market price of the Notes and our common
stock. In addition, the sale of the Notes and the shares of
common stock issuable upon conversion of the Notes depends upon the
continued maintenance of a registration statement filed with the SEC
covering the resale of the Notes, or an exemption from the registration
requirements of the Securities Act and any applicable state securities
laws; and,
|
·
|
Noteholders
are not entitled to any rights with respect to our common stock, but if
they subsequently convert their Notes and receive common stock upon such
conversion, they will be subject to all changes affecting the common
stock;
|
Our
certificate of incorporation and by-laws include anti-takeover provisions that
may enable our management to resist an unwelcome takeover attempt by a third
party.
Our
organizational documents and Delaware law contain provisions that might
discourage, delay or prevent a change in control of our company or a change in
our management. Our Board of Directors may also choose to adopt
further anti-takeover measures without stockholder approval. The
existence and adoption of these provisions could adversely affect the voting
power of holders of common stock and limit the price that investors might be
willing to pay in the future for shares of our common stock.
26
Item
2.
|
Unregistered
Sales of Equity Securities and Use of
Proceeds
|
c) Stock
Repurchases
Period
|
Total
Number of Shares Purchased
|
Average
Price Paid per Share
|
Total
Number of Shares Purchased as Part of Publicly Announced Plans or
Programs
|
Maximum
Number of Shares that May Yet be purchased Under the Plans or Programs
(1)
|
Month
#1 (June 29, 2009 – July 26, 2009)
|
-
|
|||
Month
#2 (July 27, 2009 – August 23, 2009)
|
158,379
|
$26.79
|
158,379
|
18,828,198
|
Month
#3 (August 24, 2009 – September 27, 2009)
|
-
|
-
|
-
|
-
|
Total
|
158,379
|
$26.79
|
158,379
|
18,828,198
|
1)
|
On
July 29, 2008, the Company’s Board of Directors authorized the Company to
purchase up to 20.0 million shares of
its
|
outstanding
common stock in the open market over a two year time period as the previous
program had expired.
Item
3. Defaults Upon Senior Securities
N/A
Item
4. Submission of Matter to a Vote or Security
Holder
At the
2009 Annual Meeting of Stockholders of the Company, held on November 4, 2009, in
Milpitas, California, the stockholders elected members of the Company’s Board of
Directors; approved an amendment to the Company’s 2005 Employee Stock Purchase
Plan; approved the Company’s 2009 Executive Bonus Plan; and ratified the
Company’s proposal to appoint Ernst & Young LLP as the independent
registered public accounting firm.
The vote
for nominated directors was as follows:
NOMINEE
|
FOR
|
WITHHELD
|
||
Robert
H. Swanson, Jr.
|
187,065,288
|
11,110,136
|
||
Lothar
Maier
|
189,932,561
|
8,242,863
|
||
David
S. Lee
|
149,870,239
|
48,305,185
|
||
Richard
M. Moley
|
149,578,547
|
48,596,876
|
||
Thomas
S. Volpe
|
148,604,935
|
49,570,489
|
The vote
to approve an amendment to the Company’s 2005 Employee Stock Purchase Plan to
increase the number of shares reserved for issuance by 2,000,000 shares was as
follows:
FOR
|
AGAINST
|
ABSTAIN
|
||
175,754,171
|
3,699,024
|
88,049
|
The vote
to adopt the Company’s 2009 Executive Bonus Plan was as follows:
FOR
|
AGAINST
|
ABSTAIN
|
||
176,938,498
|
2,322,333
|
280,414
|
The vote
to ratify the appointment of Ernst & Young LLP as the independent registered
public accounting firm of the Company for fiscal year 2010 was as
follows:
FOR
|
AGAINST
|
ABSTAIN
|
||
196,899,524
|
1,119,603
|
156,297
|
Item 5. Other Information
N/A
27
Item
6.
|
Exhibits
|
Exhibit
|
|||
Number
|
Description
|
||
31.1
|
Certification
of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a)
and 15d-14(a), as
|
||
adopted
pursuant to section 302 of the Sarbanes-Oxley Act of 2002
|
|||
31.2
|
Certification
of Principal Financial Officer and Principal Accounting Officer pursuant
to Exchange Act
|
||
Rules
13a-14(a) and 15d-14(a), as adopted pursuant to section 302 of the
Sarbanes-Oxley Act of 2002
|
|||
32.1
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to 18
U.S.C. Section 1350 as
|
||
adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
28
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
LINEAR
TECHNOLOGY CORPORATION
|
||
DATE:
November 5, 2009
|
BY
|
/s/Paul
Coghlan
|
Paul
Coghlan
|
||
Vice
President, Finance &
|
||
Chief
Financial Officer
|
||
(Duly
Authorized Officer and
|
||
Principal
Financial Officer)
|
29